Cita APA (7a ed.)

Roberts, K. J., Cubitt, M. F., Carlton, T. M., Rodrigues-Duarte, L., Maggiore, L., Chai, R., . . . Crowe, J. S. (2021). Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease. Nature Portfolio.

Cita Chicago Style (17a ed.)

Roberts, Kevin J., et al. Preclinical Development of a Bispecific TNFα/IL-23 Neutralising Domain Antibody as a Novel Oral Treatment for Inflammatory Bowel Disease. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Roberts, Kevin J., et al. Preclinical Development of a Bispecific TNFα/IL-23 Neutralising Domain Antibody as a Novel Oral Treatment for Inflammatory Bowel Disease. Nature Portfolio, 2021.